Publikationen von W. Zieglgänsberger

Tölle, T. R.; Ableitner, A.; Castro-Lopes, J. M.; Zieglgänsberger, W.: C-fos protein, prodynorphin mRNA, and protein kinase C are altered with distinct spatial and temporal patterns in the spinal cord of monarthritic rats. In: Proceedings of the 7th World Congress on Pain, S. 409 - 422 (Hg. Gebhardt, G. F.; Hammond, D. L.; Jensen, T. S.). IASP Press, Seattle (1994)

Tölle, T. R.; Castro-Lopes, J. M.; Zieglgänsberger, W.: Nociceptive stimulation induces immediate-early gene expression and increases GABA immunoreactivity in spinal neurons. In: Neuropeptides, Nociception and Pain, S. 385 - 402 (Hg. Höfkelt, T.; Schaible, H.-G.; Schmidt, R. F.). Chapman & Hall, Weinheim (1994)

Deisz, R. A.; Zieglgänsberger, W.: Disinhibition of neocortical neurons in vitro by GABA_B receptors. In: Epilepsy and Inhibition, S. 81 - 92 (Hg. Speckmann, E.-J.; Gutnick, M. J.). Urban & Schwarzenberg, München (1992)

Zieglgänsberger, W.: Arrays for microiontophoresis. In: Practical electrophysiological methods: a guide for In Vitro Studies in vertebrate neurobiology, S. 200 - 205 (Hg. Kettenmann, H.; Grantyn, R.). Wiley-Liss, New York (1992)

Zieglgänsberger, W.; Dodt, H.-U.; Deisz, R. A.; Pawelzik, H.: Peptides as neuronal signalling molecules. In: Integrative Biological Psychiatry, S. 93 - 104 (Hg. Emrich, H. M.; Wiegand, W.). Springer, Berlin (1992)

Zieglgänsberger, W.; Tölle, T. R.: Pharmacology of the dorsal horn of the spinal cord. In: Parenteral Drug Therapy in Spasticity and Parkinson`s Disease, S. 41 - 53 (Hg. Lakke, J. P. W. F.; Delhaas M., E.; Rutgers, A. W. F.). Parthenon, Carnforth/UK (1992)

Zieglgänsberger, W.; Zeise, M. L.: Calcium-diacetyl-homotaurinate which prevents relapse in weaned alcoholics decreases the action of excitatory amino acids in neocortical neurons of the rat in vitro. In: Novel Pharmacological Interventions for Alcoholism, S. 337 - 341 (Hg. Naranjo, C. A.; Sellers, E. M.). Springer, Heidelberg (1992)

Strian, F.; Zieglgänsberger, W.; Holsboer, F.: Neurobiologische Forschungsstrategien zur Alkoholkrankheit. In: Suchtforschung - Bestandsaufnahme und Analyse des Forschungsbedarfs, S. 50 - 75 (Hg. Projektträger "Forschung im Dienste der Gesundheit" der DLR im Auftrag des BMFT). Wirtschaftsverlag NW, Verlag für neue Wissenschaft, Bremerhaven (1991)

Tölle, T. R.; Castro-Lopes, J. M.; Evan, G.; Zieglgänsberger, W.: C-fos induction in the apinal cord folowing noxious stimulation: Prevention by opiates but not by NMDA antagonists. In: Proceedings of the VIth World Congress on Pain, S. 299 - 305 (Hg. Bond, M. R.; Charlton, J.E.; Woolf, C. J.). Elsevier, Amsterdam (1991)

Zieglgänsberger, W.: Pain research as an interdisciplinary challenge. In: Cognitive Neuroscience. Vol. 4, S. 143 - 158 (Hg. Orban, G. A.; Singer, W.; Bernsen, N. O.). Erlbaum, Hove/ U.K. (1991)

Zieglgänsberger, W.; Dodt, H.-U.; Deisz, R.; Pawelzik, H.: Peptides in neurotransmission. In: Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission, S. 371 - 380 (Hg. Fuxe, K.; Agnati, L. F.). Raven Press, New York (1991)

Zieglgänsberger, W.; Tölle, T. R.: Pharmacology of the dorsal horn of the spinal cord. In: Parental Drug Therapy in Spasticity and Parkinson`s Disease, S. 45 - 57 (Hg. Lakke, J. P. W. F.; Delhaas, E. M.; Rutgers, A. W. F.). Parthenon, Carnforth/U. K. (1991)

Deisz, R. A.; Zieglgänsberger, W.: GABA_Β receptors control GABA release of neocortical neurones. In: Presynaptic receptors and te question of autoregulation of neurotransmitter release, S. 598 - 600 (Hg. Kalsner, S.; Westfall, T. C.). Academy of Sciences, New York (1990)

Deisz, R. A.; Zieglgänsberger, W.: GABA_Β receptor-mediated frequency dependence of inhibitory postsynaptic potentials of neocortical neurons in vitro. In: GABA B Receptors in Mammalian Function, S. 239 - 257 (Hg. Bowery, N. G.; Bittiger, H.; Olpe, H.-R.). Wiley, Chichester (1990)

Siggins, G. R.; Zieglgänsberger, W.: How neuropeptides alter neuronal excitability. In: Neuropsychopharmacology, S. 488 - 505 (Hg. Bunney Jr, W. E.; Hippius, H.; Laakmann, G.; Schmauß, M.). Springer, Berlin (1990)

Zeise, M. L.; Kasparow, S.; Capogna, M.; Zieglgänsberger, W.: Calciumdiacetylhomotaurinate (Ca-AOTA) decreases the action of excitatory amino acids in the rat neocortex in vitro. In: Taurine Functional Neurochemistry, Physiology,and Cardiology, S. 237 - 242 (Hg. Pasantes-Morales, H.; Shain, W.; Martin, D. L.; del Rio, R. M.). Wiley-Liss, New York (1990)

Seidel, M. F.; Hugle, T.; Morlion, B.; Koltzenburg, M.; Chapman, V.; MaassenVanDenBrink, A.; Lane, N. E.; Perrot, S.; Zieglgaensberger, W.: Neurogenic inflammation as a novel treatment target for chronic pain syndromes. EXPERIMENTAL NEUROLOGY 356, 114108 (2022)